WHO Declares Ebola Outbreak in Congo and Uganda a Global Health Emergency

The World Health Organization has officially declared the fast-spreading Ebola outbreak in the Democratic Republic of Congo and Uganda a Public Health Emergency of International Concern. The current strain Bundibugyo is rare, poorly understood, and has zero approved vaccines or treatments, raising urgent fears among global health experts.

A Deadly Virus Crosses Borders And Rings Global Alarm Bells

The world woke up to a chilling health warning on Sunday the World Health Organization formally declared the Ebola outbreak in the Democratic Republic of Congo (DRC) and Uganda a Public Health Emergency of International Concern (PHEIC). Over 300 suspected cases and 88 deaths had already been confirmed before the announcement came. WHO Director-General Tedros Adhanom Ghebreyesus made the declaration after consulting both affected nations a move that signals how fast and how seriously the situation has deteriorated.

In a post on X, the WHO clarified that the outbreak does not meet the criteria for a pandemic emergency unlike the COVID-19 crisis and strongly advised nations against shutting borders or restricting international travel.

Also Read | Congo’s 17th Ebola Outbreak Confirmed; 65 Dead, 246 Cases Already Reported in Ituri Province

The Bundibugyo Strain: A Rarer, Harder-To-Fight Variant

What makes this outbreak especially worrying is the specific strain at its center. Health authorities confirmed the current crisis involves the Bundibugyo virus a rare variant of the Ebola family. This particular strain carries a devastating disadvantage: there are no approved vaccines or specific antiviral treatments for it anywhere in the world. While over 20 Ebola outbreaks have struck Congo and Uganda across the decades, the Bundibugyo virus has only shown up three times in history making it one of the least understood and most feared forms of the disease.

The WHO’s official statement described the situation as “extraordinary,” citing the combination of rapid geographic spread, uncertainty around the true scale of infections, and the risk of the virus amplifying in already fragile health systems.

As Director-General Tedros Adhanom Ghebreyesus stated: “After having consulted the DRC and Uganda where the Ebola disease caused by Bundibugyo virus is known to be currently occurring, I determine that the epidemic constitutes a public health emergency of international concern (PHEIC), as defined in the provisions of IHR.”

How the Outbreak Began And Where It Stands Right Now

The outbreak first came to light on Friday, when officials reported the disease spreading through Congo’s eastern Ituri province a region that shares porous borders with both Uganda and South Sudan. By Saturday, the Africa Centres for Disease Control and Prevention (Africa CDC) tallied 336 suspected cases and 87 deaths nearly all of them within DRC.

Two cases crossed into Uganda. The Ugandan health ministry confirmed an imported case a patient who traveled from DRC and later died at a hospital in Kampala, Uganda’s capital. Shortly after, the WHO confirmed a second case in Kampala. Importantly, the two patients had no apparent connection to each other, yet both had traveled from Congo pointing to ongoing, active transmission within DRC pushing outward.

The situation in Ituri is further complicated by a high initial positivity rate in lab samples eight positive results among just 13 collected samples across various areas. That figure suggests the actual outbreak could be significantly larger than what official numbers currently capture. Clusters of unexplained deaths among healthcare workers the frontline fighters of any outbreak add another red flag, pointing to gaps in infection control within local health facilities.

The Bundibugyo Virus: A Brief But Deadly History

The Bundibugyo virus first made its appearance in 2007 in Uganda’s Bundibugyo district a region bordering the DRC where it infected 149 people and killed 37. The second known outbreak erupted in 2012 in Isiro, DRC, sickening at least 57 people and claiming 29 lives. Now, in 2026, it has returned for the third time and in far larger numbers than either previous episode.

Unlike the more well-known Zaire strain of Ebola for which licensed vaccines do exist Bundibugyo remains a scientific frontier. Researchers say an experimental vaccine candidate is currently under study, but nothing is yet approved for widespread use. The absence of protective countermeasures puts both frontline healthcare workers and entire communities at much higher risk.

Why Ituri Makes Containment So Much Harder

Beyond the biology of the virus, the geography and security situation around Ituri province make this outbreak especially difficult to fight. The province is home to multiple armed groups including the Islamic State-affiliated Allied Democratic Forces and a coalition of militia factions known as CODECO who have long fought for control of the region’s mineral-rich land. Active conflict limits the ability of health workers to safely reach affected communities, restricts supply chains for critical medical equipment, and scares away the international coordination teams that outbreaks of this scale desperately need.

Population mobility in the region is exceptionally high people regularly cross into Uganda and South Sudan for markets and work which is precisely how the virus traveled to Kampala before health authorities could respond. Officials noted the two Uganda cases were unlinked, suggesting the virus may already have more pathways out of the province than anyone knows.

No PPE, No Vaccines: The Ground Reality

On the ground, health workers face a stark shortage of personal protective equipment (PPE). Given Ebola’s high transmissibility, infectious disease experts recommend full coverage head caps, goggles, face shields, gloves, gowns, and rubber boots for anyone working near an infected patient. But local officials have acknowledged that PPE manufacturing capacity simply does not exist in the affected region. “We don’t have manufacturing for PPE,” one official stated bluntly, adding that his team was urgently working to solve the problem as funding remained critically short.

What Is Ebola, And How Does It Spread?

Ebola spreads through direct contact with the blood or body fluids of an infected person. It can also pass through contaminated surfaces and objects. Symptoms arrive fast and hard fever, severe body pain, weakness, vomiting, and in some cases internal and external bleeding. The disease has an average fatality rate that hovers between 25% and 90%, depending on the strain and the speed of medical intervention. The Bundibugyo strain tends to present similarly to the deadlier Zaire strain, making early diagnosis in field conditions especially difficult without specialized laboratory testing.

Notably, the absence of a rapid field test for the Bundibugyo strain is one of the biggest gaps scientists are now scrambling to address. Currently, diagnosis requires samples sent to specialized labs a time-consuming process that delays treatment and containment during the most critical hours of exposure.

Global Response: What Happens Next

The Africa CDC has activated a multi-level emergency response, deploying surge teams to DRC and Uganda while pushing parallel readiness preparations in neighboring countries. Regional partners including WHO, South Sudan, and the African Union’s health bodies held coordination meetings even before the PHEIC declaration came through.

The WHO, for its part, is calling on countries to support the response through coordinated international action not border shutdowns, which it warns would hinder the humanitarian response while doing little to stop the virus. The organization urges medical supplies, funding, diagnostics, and surge personnel not panic.

Researchers are pressing forward on the experimental Bundibugyo vaccine candidate, but translating a lab candidate into a deployable tool takes time that outbreaks rarely afford. Until then the world watches, and Ituri burns.